{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T12:15:06Z","timestamp":1682597706958},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/ja.2017.86","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:05:54Z","timestamp":1501074354000},"page":"287-297","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogens"],"prefix":"10.1038","volume":"71","author":[{"given":"Cuixiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana K","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Fyfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger B","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy H","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce A","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"BFja201786_CR1","unstructured":"Centers for Disease Control and Prevention (CDC) 2013 Antibiotic resistance threats in the United States, 2013 http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013."},{"key":"BFja201786_CR2","unstructured":"The PEW Charitable Trusts Antibiotics currently in clinical development. December 2016 http:\/\/www.pewtrusts.org\/~\/media\/assets\/2016\/12\/antibiotics_datatable_201612.pdf?la=en."},{"key":"BFja201786_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bioorg.2014.05.008","volume":"55","author":"R Cain","year":"2014","unstructured":"Cain, R., Narramore, S., McPhillie, M., Simmons, K. & Fishwick, C. W. Applications of structure-based design to antibacterial drug discovery. Bioorg. Chem. 55, 69\u201376 (2014).","journal-title":"Bioorg. Chem."},{"key":"BFja201786_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10295-015-1723-5","volume":"43","author":"L Katz","year":"2016","unstructured":"Katz, L. & Baltz, R. H. Natural product discovery: past, present, and future. J. Ind. Microbiol. Biotechnol. 43, 155\u2013176 (2016).","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"BFja201786_CR5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2217\/fmb.15.67","volume":"10","author":"LL Silver","year":"2015","unstructured":"Silver, L. L. Natural products as a source of drug leads to overcome drug resistance. Future Microbiol. 10, 1711\u20131718 (2015).","journal-title":"Future Microbiol."},{"key":"BFja201786_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.1109755","volume":"308","author":"MG Charest","year":"2005","unstructured":"Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R. & Myers, A. G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science 308, 395\u2013398 (2005).","journal-title":"Science"},{"key":"BFja201786_CR7","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1021\/ja052151d","volume":"127","author":"MG Charest","year":"2005","unstructured":"Charest, M. G., Siegel, D. R. & Myers, A. G. Synthesis of (\u2013)-tetracycline. J. Am. Chem. Soc. 127, 8292\u20138293 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFja201786_CR8","first-page":"55","volume-title":"Topics in Medicinal Chemistry","author":"Cuixiang Sun","year":"2017","unstructured":"Sun, C. & Xiao, X.-Y. in Topics in Medicinal Chemistry. Fully synthetic tetracyclines: increasing chemical diversity to combat multidrug-resistant bacterial infections. In: Fisher, J. F. (eds). in press (Springer International Publishing AG 2017) (e-pub ahead of print 5 May 2017, doi: 10.1007\/7355_2017_11)."},{"key":"BFja201786_CR9","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1021\/acs.jmedchem.6b01903","volume":"60","author":"Y Deng","year":"2017","unstructured":"Deng, Y et al. Heterocyclyl tetracyclines. 1. 7-Trifluoromethyl-8-pyrrolidinyltetracyclines: potent, broad spectrum antibacterial agents with enhanced potency against Pseudomonas aeruginosa. J. Med. Chem. 60, 2498\u20132512 (2017).","journal-title":"J. Med. Chem."},{"key":"BFja201786_CR10","unstructured":"World Health Organization Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics (2017) http:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1."},{"key":"BFja201786_CR11","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.1021\/jm401211t","volume":"56","author":"RB Clark","year":"2013","unstructured":"Clark, R. B. et al. Synthesis and biological evaluation of 8-aminomethyltetracycline derivatives as novel antibacterial agents. J. Med. Chem. 56, 8112 (2013).","journal-title":"J. Med. Chem."},{"key":"BFja201786_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1021\/jm201465w","volume":"55","author":"X-Y Xiao","year":"2012","unstructured":"Xiao, X.-Y. et al. Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamideo-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial Agent. J. Med. Chem. 55, 597 (2012).","journal-title":"J. Med. Chem."},{"key":"BFja201786_CR13","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1021\/ol071377d","volume":"9","author":"JD Brubaker","year":"2007","unstructured":"Brubaker, J. D. & Myers, A. G. A practical, enantioselective synthetic route to a key precursor to the tetracycline antibiotics. Org. Lett. 9, 3523 (2007).","journal-title":"Org. Lett."},{"key":"BFja201786_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/acs.oprd.7b00003","volume":"21","author":"W-Y Zhang","year":"2017","unstructured":"Zhang, W.-Y. et al. Process research and development of TP-808: a key intermediate for the manufacture of synthetic tetracyclines. Org. Process Res. Dev. 21, 377 (2017).","journal-title":"Org. Process Res. Dev."},{"key":"BFja201786_CR15","unstructured":"Clinical Laboratory Standards Institute (CLSI) in: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 8th edn, (Vol 20), no. 2. CLSI document M07-A8., vol. CLSI, 940 West Valley Road, Suite 1400 (Clinical Lab Standards Institute, Wayne, Pennsylvania, 2009)."},{"key":"BFja201786_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1021\/acs.oprd.5b00404","volume":"20","author":"W-Y Zhang","year":"2016","unstructured":"Zhang, W.-Y. et al. Process development and scale-up of fully synthetic tetracycline TP-2758: a potent antibacterial agent with excellent oral bioavailability. Org. Process Res. Dev. 20, 284 (2016).","journal-title":"Org. Process Res. Dev."},{"key":"BFja201786_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/jm00027a023","volume":"37","author":"P-E Sum","year":"1994","unstructured":"Sum, P.-E. et al. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J. Med. Chem. 37, 184 (1994).","journal-title":"J. Med. Chem."},{"key":"BFja201786_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1107\/S0907444997007646","volume":"D54","author":"P Orth","year":"1998","unstructured":"Orth, P. et al. Crystallization and preliminary X-ray analysis of the Tet-repressor\/operator complex. Acta Crystallogr. Set. D. Biol. Crystallogr. D54, 99 (1998).","journal-title":"Acta Crystallogr. Set. D. Biol. Crystallogr."},{"key":"BFja201786_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy, K. K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. 2010. Lancet Infect. Dis. 10, 597 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"BFja201786_CR20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann, P., Naas, T. & Poirel, L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17, 1791 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"BFja201786_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/labinvest.3700501","volume":"87","author":"S Boyle-Vavra","year":"2007","unstructured":"Boyle-Vavra, S. & Daum, R. S. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Invest. 87, 3 (2007).","journal-title":"Lab. Invest."},{"key":"BFja201786_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh, K. N. & MacGowan, A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58, 256 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201786_CR23","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1128\/AAC.04354-14","volume":"59","author":"TH Grossman","year":"2015","unstructured":"Grossman, T. H., Murphy, T. M., Slee, A. M., Lofland, D. & Sutcliffe, J. A. Eravacycline (TP-434) is efficacious in animal models of infection. Antimicrob. Agents Chemother. 59, 2567 (2015).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja201786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja201786","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2017.86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja201786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T01:08:24Z","timestamp":1672535304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFja201786"],"URL":"https:\/\/doi.org\/10.1038\/ja.2017.86","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"assertion":[{"value":"15 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}